U.S. Oil and Gas Stock News

NYSE:MHO
NYSE:MHOConsumer Durables

A Look At M/I Homes (MHO) Valuation After Recent Share Price Volatility

M/I Homes (MHO) has been drawing attention after recent share price swings, with the stock up about 3.2% on the day but showing a 13.9% decline over the past month. See our latest analysis for M/I Homes. That 3.2% 1 day share price gain comes after a 13.9% 30 day share price decline and a mildly negative year to date share price return. However, the 3 year total shareholder return near 100% and 5 year total shareholder return near 96% highlight how longer term holders have still seen strong...
NasdaqGS:RVMD
NasdaqGS:RVMDBiotechs

Is Early RAS(ON) Pancreatic Cancer Data Altering The Investment Case For Revolution Medicines (RVMD)?

Revolution Medicines recently reported early clinical data showing that its RAS-targeting candidates daraxonrasib and zoldonrasib exhibited activity in second-line metastatic pancreatic cancer, an area with few effective treatments. This progress in directly targeting RAS(ON) via a molecular glue mechanism highlights a differentiated scientific approach in a difficult-to-treat tumor type. Next, we will examine how this early pancreatic cancer data, particularly the molecular glue RAS(ON)...
NasdaqGS:LYFT
NasdaqGS:LYFTTransportation

A Look At Lyft (LYFT) Valuation After Recent Choppy Share Price Performance

What recent performance says about Lyft (LYFT) Recent trading in Lyft (LYFT) has been choppy, with the share price up about 5.1% over the past day and 1.1% over the past week, but showing weaker returns over the past month and past 3 months. Over longer periods the picture is mixed, with a roughly 8.7% total return over the past year and a much stronger multiyear total return, while year to date performance and the past 5 years reflect sizeable drawdowns from earlier levels. See our latest...
NasdaqGM:KOD
NasdaqGM:KODBiotechs

A Look At Kodiak Sciences (KOD) Valuation After Zenkuda GLOW2 Phase 3 Success And BLA Plans

Kodiak Sciences (KOD) is back in focus after reporting that its GLOW2 Phase 3 study of Zenkuda in diabetic retinopathy met key efficacy and safety endpoints, supporting a multi-indication, BLA-ready profile. See our latest analysis for Kodiak Sciences. The Zenkuda update arrives alongside sharp recent moves in the stock, with a 74.46% 7 day share price return and a 42.24% 30 day share price return. The 1 year total shareholder return is very large, suggesting momentum has picked up sharply...
NYSE:STNG
NYSE:STNGOil and Gas

Scorpio Tankers (STNG) Valuation After Fleet Sales And Newbuilding Plans

Scorpio Tankers (STNG) has been actively reshaping its fleet by agreeing to sell multiple MR and LR2 product tankers, including two 2015 built scrubber fitted vessels, while also arranging newbuilding deliveries through 2029. See our latest analysis for Scorpio Tankers. The latest vessel sales and newbuilding commitments come as Scorpio Tankers’ share price sits at US$74.66, with a 90 day share price return of 46.88% and a 1 year total shareholder return of 102.23%. This points to strong...
NasdaqGS:TMUS
NasdaqGS:TMUSWireless Telecom

T-Mobile US (TMUS) Valuation Check As New Device Fees Stir Fresh Questions On Customer Churn

T-Mobile US (TMUS) is drawing fresh attention after raising device restocking fees and introducing a $35 Device Connection Charge for Apple purchases, just as it faces higher customer cancellations and tougher wireless competition. See our latest analysis for T-Mobile US. The recent fee changes come after a softer 1-month share price return of 3.25% and a 1-day pullback of 1.83%, although the 3-year total shareholder return of 49.30% and 5-year total shareholder return of 66.21% still reflect...
OTCPK:FKYS
OTCPK:FKYSBanks

First Keystone (OTCPK:FKYS) Quarterly Loss Challenges Bullish Narrative Around Stable Net Interest Margin

First Keystone (FKYS) just wrapped up FY 2025 with fourth quarter revenue of US$7.8 million and a basic EPS loss of US$0.10, while the trailing twelve months show total revenue of US$40.3 million and EPS of US$0.99. Over recent periods the company has seen quarterly revenue move from US$10.4 million in Q4 2024 to US$11.5 million in Q2 2025 before landing at US$7.8 million in Q4 2025, with basic EPS shifting from US$0.37 in Q4 2024 to US$0.47 in Q2 2025 before slipping into a small loss in the...
NasdaqGM:HROW
NasdaqGM:HROWPharmaceuticals

How Investors May Respond To Harrow (HROW) Upsizing Its 2030 Unsecured Notes For Growth Flexibility

Harrow recently completed a private fixed‑income offering of US$50.0 million in 8.625% senior unsecured notes due September 15, 2030, issued at 100.25% of par and guaranteed by certain subsidiaries. The new notes, fungible with Harrow’s existing US$250.0 million 2030 notes and sold to qualified institutional buyers under Rule 144A and Regulation S, further reshape the company’s capital structure to support general corporate and growth initiatives. Now we’ll examine how this additional...
NYSE:CRH
NYSE:CRHBasic Materials

A Look At CRH (NYSE:CRH) Valuation After Recent Share Price Volatility

CRH (NYSE:CRH) has drawn investor attention after recent share price volatility, with the stock closing at US$105.12 and showing mixed returns across the past week, month, past 3 months, and year to date. See our latest analysis for CRH. The recent 1 day share price return of 3.15% comes after a weaker stretch, with 30 day and year to date share price returns of 12.39% and 16.86% declines. At the same time, 1 year, 3 year, and 5 year total shareholder returns of 19.58%, 122.30%, and 160.89%...
NYSE:RJF
NYSE:RJFCapital Markets

Is Raymond James (RJF) Management Turnover Quietly Reshaping Its Long‑Term Wealth Strategy?

Raymond James said that Independent Contractor Division director Kirk Bell has been appointed president of the division, effective April 1, 2026, joining both the firm’s Senior Leadership and Private Client Group Executive Leadership teams after prior president Shannon Reid’s resignation. This leadership change comes as the firm balances softer capital markets activity with growth in asset management and private client revenues ahead of its upcoming fiscal Q2 2026 earnings release. Next,...
NYSE:ALSN
NYSE:ALSNMachinery

Allison Transmission Buyout Of Dana Unit Reshapes Growth And Valuation Profile

Allison Transmission Holdings (NYSE:ALSN) is acquiring Dana’s Off-Highway business, expanding its reach beyond on-highway applications. The deal adds exposure to off-highway markets such as construction, agriculture and mining, widening Allison’s addressable customer base. Investors now have new information to assess Allison’s mix of end markets, revenue sources and integration priorities. Allison Transmission Holdings, trading at $117.06, has seen its share price rise 18.3% year to date...
NasdaqGM:OLLI
NasdaqGM:OLLIMultiline Retail

The Bull Case For Ollie's (OLLI) Could Change Following Scale-Driven Economics Highlighted In Q4 FY2025 Results

Ollie's Bargain Outlet Holdings recently reported a strong fourth-quarter fiscal 2025 performance, emphasizing that greater scale is now improving its underlying economics beyond simple growth. Management highlighted how retail consolidation is enhancing access to closeout merchandise, real estate locations, and supplier bargaining power, supporting plans for roughly 10% annual unit growth and low-single-digit comparable sales. Next, we'll examine how this emphasis on scale-driven...
NYSE:PNC
NYSE:PNCBanks

Is PNC Financial Services Group (PNC) Pricing Reflect Its Recent 1‑Year Share Price Jump

If you are wondering whether PNC Financial Services Group's current share price still offers value, it helps to line up the recent returns against what the underlying business might be worth. The stock last closed at US$208.09, with returns of 0.8% over 7 days, a 2.0% decline over 30 days, a 1.6% decline year to date, and a 23.5% return over 1 year, alongside 91.0% and 40.6% returns over 3 and 5 years respectively. Recent price moves sit against a backdrop of ongoing coverage of large US...
NYSE:WK
NYSE:WKSoftware

Did Workiva's (WK) New AI-Focused CFO Just Recast Its Governance and Compliance Investment Narrative?

Earlier this year, Workiva appointed Barbara Larson as executive vice president and chief financial officer, drawing on her prior finance leadership roles at Workday and VMware to help oversee its AI-enabled governance, risk, compliance and sustainability platform, which is guiding toward US$1.00 billion in revenue in 2026. Her emphasis on embedding AI more deeply into Workiva’s platform to respond to rising regulatory demands highlights how leadership decisions could shape the company’s...
NYSE:DAVA
NYSE:DAVAIT

Endava (NYSE:DAVA) Earnings Swing To Loss Challenges Bullish Profitability Narratives

Endava (NYSE:DAVA) has just turned in a mixed Q2 2026 scorecard, with revenue of £184.1 million, a basic EPS loss of £0.13 and net income loss of £6.9 million, set against a trailing twelve month picture that shows £743.9 million of revenue, a small EPS loss of £0.05 and a net income loss of £2.9 million. Over the past few quarters, revenue has moved from £195.6 million and EPS of £0.12 in Q2 2025 to £184.1 million and EPS of a £0.13 loss in Q2 2026, while quarterly net income shifted from a...
NYSE:AGX
NYSE:AGXConstruction

Broadcom And 2 More Power Grid Technology Stocks With Deep Backlogs

Global markets are wrestling with stubborn inflation risks, volatile energy prices, and shifting central bank expectations, which is pushing many investors to look more closely at real world infrastructure. The power grid sits at the heart of that topic, linking AI data centers, electrified transport, and everyday homes to reliable energy. Our Power Grid Technology Stocks screener filters for profitable companies that build and equip this backbone, focusing on those already earning money from...
NasdaqGS:SRRK
NasdaqGS:SRRKBiotechs

Why Scholar Rock Holding (SRRK) Is Up 16.2% After Apitegromab BLA Resubmission With FDA-Aligned Manufacturing

On 31 March 2026, Scholar Rock announced it had resubmitted its Biologics License Application to the FDA for apitegromab in spinal muscular atrophy, now incorporating both the Catalent Indiana site and a second U.S.-based fill-finish facility in line with recent regulatory guidance. The resubmission, coming after an earlier Complete Response Letter that cited only third-party manufacturing observations, highlights how Scholar Rock has worked with Novo Nordisk’s Catalent unit and the FDA to...
NYSE:KTB
NYSE:KTBLuxury

Heritage Fashion Collaborations With J.Crew and Dr. Scholl’s Might Change The Case For Investing In Kontoor Brands (KTB)

In March 2026, Dr. Scholl’s Shoes announced a limited-edition collaboration with Kontoor Brands’ Wrangler, and J.Crew introduced an exclusive Lee x J.Crew capsule, both featuring Americana-inspired footwear, denim, and apparel across multiple categories and price points. These collaborations highlight how Kontoor is using heritage partnerships and fashion-forward capsules to broaden its reach, refresh brand perception, and tap into new style-minded consumer groups. Next, we’ll examine how...
NYSE:DX
NYSE:DXMortgage REITs

Is It Time To Reassess Dynex Capital (DX) After Recent Share Price Swings?

If you are wondering whether Dynex Capital is priced attractively at around US$12.76, it helps to separate short term share price swings from what the underlying value might suggest. The stock has recently shown mixed returns, with a 2.4% gain over the last 7 days, a 9.1% decline over 30 days, and year to date and 1 year returns of 9.4% decline and 15.2% respectively, while the 3 year and 5 year returns sit at 60.2% and 23.8%. Recent coverage has focused on how income focused investors view...
NYSE:NXDT
NYSE:NXDTREITs

NexPoint Diversified Real Estate Trust (NXDT) Q4 FFO Rebound Tests Bearish Narratives

NexPoint Diversified Real Estate Trust (NXDT) has wrapped up FY 2025 with fourth quarter total revenue of US$19.1 million, basic EPS of a US$0.75 loss, and funds from operations of US$86.1 million. This rounds out a trailing 12 month revenue line of US$86.0 million and a net loss of US$130.2 million. Over recent quarters, revenue has moved from US$28.7 million in Q1 2025 to US$21.2 million in Q2, US$16.9 million in Q3, and US$19.1 million in Q4. Quarterly basic EPS has ranged from a US$0.99...
NasdaqGS:OKTA
NasdaqGS:OKTAIT

Okta (OKTA) Valuation Check After Geopolitical Relief Rally And Mixed Shareholder Returns

Geopolitics, market relief and Okta’s recent move Okta (OKTA) gained 2.7% after reports that the U.S. may be willing to end its military campaign against Iran, easing fears around extended geopolitical tension and energy price shocks for equity markets. See our latest analysis for Okta. Beyond today’s relief rally, Okta’s recent moves have been mixed, with a 1 month share price return of 8.57% contrasting with a 1 year total shareholder return decline of 24.82%. Short term momentum is...
NYSE:MAIN
NYSE:MAINCapital Markets

Does MAIN’s New 6.95% Notes Shift the Risk‑Return Balance for Main Street Capital?

Main Street Capital Corporation recently completed a US$204.12 million fixed‑income offering, issuing 6.95% senior unsecured notes due March 1, 2029, at a slight discount and with callable features. This additional debt capital supports Main Street Capital’s lending capacity while complementing its internally managed model and emphasis on consistent monthly and supplemental dividends for shareholders. We’ll now examine how this new 6.95% debt financing could influence Main Street Capital’s...
NasdaqGS:ATRO
NasdaqGS:ATROAerospace & Defense

Is It Time To Reassess Astronics (ATRO) After A 17% Monthly Pullback?

Wondering if Astronics at US$66.73 is priced for perfection or still offers value? This article breaks down what the current share price might be implying. The stock has seen a 1.7% decline over the past week and a 17.2% decline over the past month, yet it is still up 17.9% year to date and 169.8% over the last year, with a very large return over three years and a 262.1% return over five years. Recent coverage has focused on Astronics as an aerospace and defense supplier, including attention...
NasdaqGS:CINF
NasdaqGS:CINFInsurance

Cincinnati Financial’s 65 Year Dividend Record Meets Valuation And Earnings Test

Cincinnati Financial (NasdaqGS:CINF) has extended its dividend growth streak to 65 consecutive years. The company continues to emphasize disciplined underwriting and careful risk selection across its insurance portfolio. Management highlights investment discipline as a key support for its long running dividend track record. Cincinnati Financial focuses on property and casualty insurance, an area that regularly faces weather events and other large loss scenarios. In this context, a 65 year...